BioCentury
ARTICLE | Clinical News

Acanya gel regulatory update

October 27, 2008 7:00 AM UTC

FDA approved an NDA from Dow for topical Acanya gel to treat acne vulgaris in patients 12 years and older. Acanya is a combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% in a gel. ...